Skip to content

Medical-device intelligence

Fujirebio Diagnostics, Inc.: FDA clearances and recalls

Research Fujirebio Diagnostics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

44 clearance records and 8 recall records in the covered releases, across 1 source company names and 23 product codes. Dated history runs from Nov 17, 1989 to Dec 16, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202517
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

52 matching records
Device / recordCompany in FDA recordSourceSource date
LUMIPULSE G1200 System, LUMIPULSE G CA 125II Immunoreaction Cartridges, LUMIPULSE G CA 125II CalibratorsK142895 · LTKFujirebio Diagnostics,Inc.510(k)May 21, 2015FDA decision date
ARCHITECT GALECTIN-3 Reagent Kit, ARCHITECT GALECTIN-3 CALIBRATORS, ARCHITECT GALECTIN-3 CONTROLSK140436 · OSXFujirebio Diagnostics,Inc.510(k)Dec 23, 2014FDA decision date
FDI LEVEL I AND LEVEL II GLUCOSE CONTROLS FOR THE EMBRACE NO CODEK133197 · JJXFujirebio Diagnostics,Inc.510(k)Jan 17, 2014FDA decision date
FDI GLUCOSE CONTROL SOLUTION FOR USE WITH ACCU-CHEK AVIVAK123612 · JJXFujirebio Diagnostics,Inc.510(k)Jan 17, 2013FDA decision date
ROMA (HE4 EIA + ARCHITECT CA 125 II)K103358 · ONXFujirebio Diagnostics,Inc.510(k)Sep 1, 2011FDA decision date
FUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROLK103676 · OIUFujirebio Diagnostics,Inc.510(k)Jul 19, 2011FDA decision date
FUJIREBIO DIAGNOSTICS VITAMIN D CONTROLK110641 · JJXFujirebio Diagnostics,Inc.510(k)May 27, 2011FDA decision date
CYFRA 21-1 EIA MODEL 211-10K100831 · OVKFujirebio Diagnostics,Inc.510(k)May 26, 2011FDA decision date
FDI GLUCOSE CONTROL SOLUTION FOR AVIVAK110436 · JJXFujirebio Diagnostics,Inc.510(k)Apr 20, 2011FDA decision date
MESOMARK Humanitarian Device. Authorized by Federal Law for use as an aid in monitoring of patients diagnosed with mesothelioma. Each kit contain…Z-1606-2011 · OAWFujirebio Diagnostics, Inc.RecallMar 8, 2011FDA classification date
FDI GLUCOSE CONTROL SOLUTION FOR FREESTYLEK103450 · JJXFujirebio Diagnostics,Inc.510(k)Jan 25, 2011FDA decision date
FUJIREBIO DIAGNOSTICS TUMOR MARKER CONTROL MODEL 108-20K101809 · JJYFujirebio Diagnostics,Inc.510(k)Oct 5, 2010FDA decision date
FDI GLUCOSE CONTROL SOLUTIONSK102260 · JJXFujirebio Diagnostics,Inc.510(k)Sep 24, 2010FDA decision date
ARCHITECT HE4, ARCHITECT HE4 CALIBRATORS AND ARCHITECT HE4 CONTROLS, MODELS 2, 2P54, 2P54-01, 2P54-10 SP54-01,K093957 · OIUFujirebio Diagnostics,Inc.510(k)Mar 18, 2010FDA decision date
FDI GLUCOSE CONTROL LEVELS 1, 2 AND 3K092645 · JJXFujirebio Diagnostics,Inc.510(k)Sep 5, 2009FDA decision date
ARCHITECT CYCLOSPORINEK080751 · MKWFujirebio Diagnostics,Inc.510(k)Sep 11, 2008FDA decision date
HE4 EIA, MODEL: 404-10 USK072939 · OIUFujirebio Diagnostics,Inc.510(k)Jun 9, 2008FDA decision date
ARCHITECT SIROLIMUS ASSAYK070822 · NRPFujirebio Diagnostics,Inc.510(k)Sep 28, 2007FDA decision date
ARCHITECT TACROLIMUS: MODEL 1L77K070820 · MLMFujirebio Diagnostics,Inc.510(k)Aug 1, 2007FDA decision date
ARCHITECT BNP ASSAY, MODEL 8K28K060964 · NBCFujirebio Diagnostics,Inc.510(k)May 25, 2006FDA decision date
VITROS CA 19-9K052889 · NIGFujirebio Diagnostics,Inc.510(k)Dec 20, 2005FDA decision date
ARCHITECT CA 19-9XR ASSAYK052000 · NIGFujirebio Diagnostics,Inc.510(k)Oct 25, 2005FDA decision date
ARCHITECT CA 15-3 ASSAYK042732 · MOIFujirebio Diagnostics,Inc.510(k)Dec 22, 2004FDA decision date
ARCHITECT CA 125 II ASSAYK042731 · LTKFujirebio Diagnostics,Inc.510(k)Nov 19, 2004FDA decision date
AXSYM CORTISOL ASSAYK033731 · JFTFujirebio Diagnostics,Inc.510(k)Feb 20, 2004FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗